The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days
Yazarlar (5)
Bolu Abant İzzet Baysal Üniversitesi, Türkiye
Dr. Öğr. Üyesi Mahmut SÜRMELİ
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Munzur Üniversitesi, Türkiye
Erciyes Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
|
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale |
| Dergi Adı | CLINICAL NURSING RESEARCH |
| Dergi ISSN | 1054-7738 Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q2 |
| Makale Dili | İngilizce |
| Basım Tarihi | 03-2023 |
| Cilt No | 32 |
| Sayı | 3 |
| Sayfalar | 608 / 617 |
| DOI Numarası | 10.1177/10547738231155729 |
| Makale Linki | http://dx.doi.org/10.1177/10547738231155729 |
| Özet |
| The adverse physical, psychological, and mental health consequences associated with COVID-19 illness are well-documented. However, how specific symptoms change over time and how COVID-19 affects one's day-to-day activities of daily living (ADL), Quality of Life (QoL), sleep quality, and fatigue severity are not well described. This longitudinal and descriptive study examined the changes in COVID-19 symptoms, ADL, QoL, sleep quality, and fatigue severity within the first 20 days. A convenience sample ( = 41) of non-hospitalized SARS-CoV-2 positive patients were recruited and followed for 20 days. Participants completed self-report measures: COVID-19 symptoms, ADL, QoL, sleep quality, and fatigue severity at days: 1, 10, and 20 following a diagnosis. Findings revealed that symptoms decreased over 20 days ( < .001). In parallel with the decrease in symptoms, QoL and ADL improved over 20 days ( < .05). However, sleep quality and fatigue severity did not improve within 20 days ( > .05). Our findings contribute to the growing evidence that COVID-19 symptoms can linger, especially fatigue and sleep quality, that affect overall day-to-day functioning for at least 20 days after diagnosis. To mitigate the effect of COVID-19 on QOL and ADL, findings underscore the need for clinicians to work collaboratively with patients to develop a symptom management plan for a variety of symptoms including fatigue and sleep quality. Beginning to repurpose existing self-management strategies for the longer term COVID-19 symptoms could be beneficial and help to optimize patient outcomes. Future work should examine these variables over a longer timeframe and among different samples of non-hospitalized patients. |
| Anahtar Kelimeler |
| COVID-19 | activities of daily living | fatigue | quality of life | sleep quality |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| WoS | 1 |